JP2013049653A5 - - Google Patents

Download PDF

Info

Publication number
JP2013049653A5
JP2013049653A5 JP2011189583A JP2011189583A JP2013049653A5 JP 2013049653 A5 JP2013049653 A5 JP 2013049653A5 JP 2011189583 A JP2011189583 A JP 2011189583A JP 2011189583 A JP2011189583 A JP 2011189583A JP 2013049653 A5 JP2013049653 A5 JP 2013049653A5
Authority
JP
Japan
Prior art keywords
dysuria
patient
female
hypotension
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011189583A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013049653A (ja
JP6031722B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2011189583A priority Critical patent/JP6031722B2/ja
Priority claimed from JP2011189583A external-priority patent/JP6031722B2/ja
Publication of JP2013049653A publication Critical patent/JP2013049653A/ja
Publication of JP2013049653A5 publication Critical patent/JP2013049653A5/ja
Application granted granted Critical
Publication of JP6031722B2 publication Critical patent/JP6031722B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011189583A 2011-08-31 2011-08-31 女性の排尿障害の治療剤 Expired - Fee Related JP6031722B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011189583A JP6031722B2 (ja) 2011-08-31 2011-08-31 女性の排尿障害の治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011189583A JP6031722B2 (ja) 2011-08-31 2011-08-31 女性の排尿障害の治療剤

Publications (3)

Publication Number Publication Date
JP2013049653A JP2013049653A (ja) 2013-03-14
JP2013049653A5 true JP2013049653A5 (enExample) 2014-10-16
JP6031722B2 JP6031722B2 (ja) 2016-11-24

Family

ID=48012019

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011189583A Expired - Fee Related JP6031722B2 (ja) 2011-08-31 2011-08-31 女性の排尿障害の治療剤

Country Status (1)

Country Link
JP (1) JP6031722B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6482243B2 (ja) * 2013-11-12 2019-03-13 キッセイ薬品工業株式会社 末梢神経障害における感覚神経障害の予防または治療用医薬組成物
JP6602181B2 (ja) * 2015-11-30 2019-11-06 公立大学法人横浜市立大学 血圧制御異常の新規治療法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001288115A (ja) * 2001-02-07 2001-10-16 Yamanouchi Pharmaceut Co Ltd 下部尿路症治療剤
US20060018959A1 (en) * 2002-12-16 2006-01-26 Kissei Pharmaceutical Co. Ltd. Solid drug for oral use

Similar Documents

Publication Publication Date Title
JP2015524444A5 (enExample)
JP2014521735A5 (enExample)
NZ714963A (en) Compositions and methods for treating anemia
JP2019503365A5 (enExample)
FI3504187T3 (fi) Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten
JP2013522303A5 (enExample)
JP2017506624A5 (enExample)
WO2011009020A3 (en) Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
NZ604029A (en) Methods of treating bladder cancer
JP2012532874A5 (enExample)
JP2013541583A5 (enExample)
RU2014150942A (ru) Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона
JP2013518124A5 (enExample)
NZ593467A (en) Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
WO2017182873A3 (en) Peptide-oligourea foldamer compounds and methods of their use
JP2015537009A5 (enExample)
JP2015527374A5 (enExample)
JP2015522603A5 (enExample)
JP2018517759A5 (enExample)
JP2014504636A5 (enExample)
MX341660B (es) Agonista del receptor de ghrelina para el tratamiento de caquexia.
JP2012525358A5 (enExample)
JP2017516842A5 (enExample)
JP2017061488A5 (enExample)